Brief: China Resources Pharma's Long Position In Immunotech Biopharm Rises To 10% - HKEX Filing
July 21 (Reuters) - Hong Kong stock exchange filing:
* CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED'S LONG
POSITION IN
IMMUNOTECH BIOPHARM 6978.HK INCREASED TO 10.0% ON JULY 20 FROM
0.0% - HKEX FILING
Source text in English : https://bit.ly/3wOMiU4
Further company coverage: 6978.HK 3320.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Immunotech Biopharm
See all newsBrief: Immunotech Biopharm Gets Approval In Sept 2025 For Clinical Translational Application Of Atl In Hainan
Brief: Immunotech Biopharm Receives Notice Of Rejection For Conditional New Drug Application For EAL Dated 27 April 2026
Brief: Trading In Shares Of Immunotech Biopharm Will Be Halted At 1:00 PM On April 28, HKEX Says
Brief: Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million
Brief: Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN